Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
暂无分享,去创建一个
J. Machiels | S. Hansen | S. Oudard | I. Bodrogi | G. Gravis | J. D. de Bono | J. Bono | Sunil Gupta | M. Roessner | I. Kocák | A. Sartor | M. Ozguroglu | M. Mackenzie | L. Shen | Mary J Mackenzie | A Oliver Sartor